Peroxiredoxin‐I is an autoimmunogenic tumor antigen in non‐small cell lung cancer
Authors:
- Yung Joon YooYYYung Joon Yoo
- 27 April 2005
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (13) , 2873-2877
Abstract
In eukaryotic cells, peroxiredoxins are both antioxidants and regulators of H2O2‐mediated signaling. We previously found that peroxiredoxin‐I (Prx‐I) was overexpressed in non‐small cell lung cancer (NSCLC) tissue. Since overexpressed protein can induce a humoral immune response, we examined whether serum from NSCLC patients exhibited immunoreactivity against Prx‐I using Western blotting. We found that 25 (47%) of 53 NSCLC patients tested had autoantibodies against Prx‐I in their sera, whereas such activity was detected in 4 (8%) sera from 50 healthy subjects. Prx‐I itself was detected in the sera from 18 (34%) of 53 NSCLC patients but in only 1 (2%) serum from 50 controls. Moreover, 17% of NSCLC sera were positive to both Prx‐I antibody and antigen but none in control sera. The data indicate both Prx‐I autoantibody and circulating antigen are potential biomarkers for use in serological diagnosis of NSCLC. Interestingly enough, we found that Prx‐I was secreted by lung adenocarcinoma cells (A549) but not by non‐cancer lung cells (BEAS 2B) or breast cancer cells (MCF7). This cell culture study suggests the possibility of Prx‐I secretion from NSCLC tumor tissues.Keywords
This publication has 32 references indexed in Scilit:
- Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC)Lung Cancer, 2003
- Proteomic applications for the early detection of cancerNature Reviews Cancer, 2003
- The case for early detectionNature Reviews Cancer, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Emerging molecular markers of cancerNature Reviews Cancer, 2002
- Serum anti-p53 antibodies in lung cancer: comparison with established tumor markersLung Cancer, 2001
- CEA, CYFRA21-1 and SCC in non-small cell lung cancerLung Cancer, 1995
- Serum p53 antibodies as early markers of lung cancerNature Medicine, 1995
- Serum tumour markers in lung cancer: history, biology and clinical applicationsEuropean Respiratory Journal, 1994
- CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluationEuropean Journal of Cancer, 1994